ProPhase pledges to enter VMS, launches 3 cough/cold SKUs

DOYLESTOWN, Pa. — ProPhase Laboratories on Wednesday announced the introduction of three new product line extensions for this fall's cough/cold season. ProPhase will introduce Cold-EEZE Multi-Symptom Relief for Cold and Flu lozenges, Cold-EEZE Daytime and Nighttime Multi-Symptom Relief in liquid forms (one for adults and one for children) and Cold-EEZE Natural Allergy Relief caplets for indoor and outdoor allergies. 

 

Two additional Cold-EEZE branded products will be introduced to the trade in February of 2016, noted Ted Karkus, ProPhase CEO.

 

“In addition to the continued development and commercialization of new Cold-EEZE branded products, we are also continuing the process of implementing a series of development and pre-commercialization initiatives in the dietary supplement category,” he said. “We are exploring various ways to introduce these new dietary supplement products to consumers which may include direct response TV.”

 

Karkus expects to launch into the VMS space by the end of the year or early in 2016.